IONS peer analysis
Ionis Pharmaceuticals (IONS) against its competitors: price, today's move, 1-year return and market value side by side.
IONS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALNY Alnylam | $157.89 | -4.31% | -64.88% | $22.10B |
| BBIO BridgeBio Pharma | $74.97 | 0.02% | 18.30% | $14.60B |
| BIIB Biogen | $248.96 | -1.84% | 66.41% | $37.49B |
| BMRN BioMarin | $53.67 | -8.27% | 3.39% | $11.33B |
| NTLA Intellia | $11.67 | -6.42% | -4.85% | $1.75B |
| PTCT PTC Therapeutics | $60.84 | 1.45% | -10.67% | $5.01B |
| RARE Ultragenyx | $16.32 | 1.37% | -53.60% | $1.59B |
| SRPT Sarepta Therapeutics | $18.32 | -1.64% | -21.23% | $1.97B |
| IONS Ionis Pharmaceuticals | $41.21 | -5.31% | -44.44% | $7.23B |
- IONS's peers: ALNY (Alnylam), BBIO (BridgeBio Pharma), BIIB (Biogen), BMRN (BioMarin), NTLA (Intellia), PTCT (PTC Therapeutics), RARE (Ultragenyx), SRPT (Sarepta Therapeutics).
Updated 2026-11-03 00:01 UTC